David Lucchino
Directeur/Membre du Conseil chez The Multiple Myeloma Research Foundation, Inc.
Fortune : 750 221 $ au 30/06/2024
Profil
David L.
Lucchino was the founder of Semprus BioSciences Corp., founded in 2005, where he served as President, Chief Executive Officer & Director from 2007 to 2012.
He was also the founder of Frequency Therapeutics, Inc., founded in 2014, where he held the position of President, CEO, Secretary & Director.
Mr. Lucchino is also the founder of Lauchcyte.
Currently, he holds the position of Director at The Multiple Myeloma Research Foundation, Inc., Director at National Outdoor Leadership School, Independent Director at Korro Bio, Inc. since 2023, and Member-College of Fellows at American Institute For Medical & Biological Engineering.
In the past, he served as President & Chief Executive Officer of Entrega, Inc. from 2014 to 2016, Chairman of Massachusetts Biotechnology Council, Director of Lipella Pharmaceuticals, Inc., Director of Advanced Medical Technology Association, Senior Associate at Polaris Growth Management LLC from 2005 to 2007, and Trustee at Mount Auburn Hospital from 2007 to 2021.
Mr. Lucchino has an undergraduate degree from Denison University in 1991, an MBA from MIT Sloan School of Management in 2006, and a graduate degree from S.I.
Newhouse School of Public Communications in 1997.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,24% | 11/06/2024 | 22 150 ( 0,24% ) | 750 221 $ | 30/06/2024 |
Postes actifs de David Lucchino
| Sociétés | Poste | Début |
|---|---|---|
The Multiple Myeloma Research Foundation, Inc.
 The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT. | Directeur/Membre du Conseil | - |
American Institute For Medical & Biological Engineering
 American Institute For Medical & Biological Engineering Miscellaneous Commercial ServicesCommercial Services American Institute For Medical & Biological Engineering engages in research and development of medical and biological engineering. The private company is based in Washington. | Corporate Officer/Principal | - |
National Outdoor Leadership School
 National Outdoor Leadership School Miscellaneous Commercial ServicesCommercial Services National Outdoor Leadership School (NOLS) is a nonprofit organization that has been the leader in wilderness education since 1965. The non-profit company is based in Lander, WY and has subsidiaries in Canada. The company's mission is to help individuals become confident leaders through outdoor education. | Directeur/Membre du Conseil | - |
Anciens postes connus de David Lucchino
| Sociétés | Poste | Fin |
|---|---|---|
| KORRO BIO, INC. | Fondateur | 01/11/2023 |
Mount Auburn Hospital
 Mount Auburn Hospital Hospital/Nursing ManagementHealth Services Mount Auburn Hospital provides healthcare services. It offers care and treatment for addiction, alcohol abuse, arthritis care, athletic injury, breast health, blood disorders, cancer, and colon and rectal surgery. The company was founded in 1886 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 01/01/2021 |
Entrega, Inc.
 Entrega, Inc. Pharmaceuticals: MajorHealth Technology Entrega, Inc. develops oral drug delivery technologies. The firm’s platform enables novel applications in a variety of fields, such as disease management and tracking in the burgeoning mobile health arena. Its proprietary technology seeks to solve the oral delivery problem with an engineering solution that protects the payload and delivers biological molecules, drug substances and nanoparticles. The company was founded by Samir Mitragotri in 2010 and is headquartered in Boston, MA. | Directeur Général | 01/06/2016 |
Semprus BioSciences Corp.
 Semprus BioSciences Corp. Pharmaceuticals: GenericHealth Technology Semprus BioSciences, headquartered in Cambridge, Massachusetts, is a venture-backed biomedical company with a dual mission: to provide complication-free medical devices designed to preserve patients' long-term health and quality-of-life and to contribute to healthcare cost efficiencies. Their innovative, multi-faceted approach to durable surface modifications signifies a breakthrough in medical device technology. Their current focus is to enable the first permanently dual-functional (anti-colonization and anti-thrombogenic) vascular access catheter with a single surface modification. Founded out of the Massachusetts Institute of Technology's Langer Lab, the company has developed the next-generation biofunctional surface platform - which is focused on achieving clinical benefits that far exceed current market offerings containing silver, heparin, and antibiotic coatings. Through covalent chemical bonding of their Semprus Surfaces™, a permanent non-leaching biomaterial modification to the device surface, their technology is expected to vastly improve patient outcomes by preventing serious medical complications, such as infection, blood clots, improper healing, and cell overgrowth. They have assembled a world class product development team - scientists, industry executives and clinical experts - who specialize in reducing such complications at the confluence of the human body and implantable devices. | Fondateur | 01/06/2012 |
Polaris Growth Management LLC
 Polaris Growth Management LLC Investment ManagersFinance Polaris Partners is an Independent Venture Capital firm founded in 1996 by Stephen D. Arnold, Jonathan A. Flint and Terrance G. McGuire. Polaris Partners is headquartered in Waltham. | Analyste en capital-investissement | 31/05/2007 |
Formation de David Lucchino
| Denison University | Undergraduate Degree |
| MIT Sloan School of Management | Masters Business Admin |
| S.I. Newhouse School of Public Communications | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LIPELLA PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 11 |
|---|---|
Semprus BioSciences Corp.
Semprus BioSciences Corp. Pharmaceuticals: GenericHealth Technology Semprus BioSciences, headquartered in Cambridge, Massachusetts, is a venture-backed biomedical company with a dual mission: to provide complication-free medical devices designed to preserve patients' long-term health and quality-of-life and to contribute to healthcare cost efficiencies. Their innovative, multi-faceted approach to durable surface modifications signifies a breakthrough in medical device technology. Their current focus is to enable the first permanently dual-functional (anti-colonization and anti-thrombogenic) vascular access catheter with a single surface modification. Founded out of the Massachusetts Institute of Technology's Langer Lab, the company has developed the next-generation biofunctional surface platform - which is focused on achieving clinical benefits that far exceed current market offerings containing silver, heparin, and antibiotic coatings. Through covalent chemical bonding of their Semprus Surfaces™, a permanent non-leaching biomaterial modification to the device surface, their technology is expected to vastly improve patient outcomes by preventing serious medical complications, such as infection, blood clots, improper healing, and cell overgrowth. They have assembled a world class product development team - scientists, industry executives and clinical experts - who specialize in reducing such complications at the confluence of the human body and implantable devices. | Health Technology |
Polaris Growth Management LLC
Polaris Growth Management LLC Investment ManagersFinance Polaris Partners is an Independent Venture Capital firm founded in 1996 by Stephen D. Arnold, Jonathan A. Flint and Terrance G. McGuire. Polaris Partners is headquartered in Waltham. | Finance |
Advanced Medical Technology Association
 Advanced Medical Technology Association Miscellaneous Commercial ServicesCommercial Services Advanced Medical Technology Association is a trade association which provides medical technology solutions. The company was founded in 1974 and is headquartered in Washington, DC. | Commercial Services |
Mount Auburn Hospital
Mount Auburn Hospital Hospital/Nursing ManagementHealth Services Mount Auburn Hospital provides healthcare services. It offers care and treatment for addiction, alcohol abuse, arthritis care, athletic injury, breast health, blood disorders, cancer, and colon and rectal surgery. The company was founded in 1886 and is headquartered in Cambridge, MA. | Health Services |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Commercial Services |
The Multiple Myeloma Research Foundation, Inc.
The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT. | Commercial Services |
American Institute For Medical & Biological Engineering
American Institute For Medical & Biological Engineering Miscellaneous Commercial ServicesCommercial Services American Institute For Medical & Biological Engineering engages in research and development of medical and biological engineering. The private company is based in Washington. | Commercial Services |
National Outdoor Leadership School
National Outdoor Leadership School Miscellaneous Commercial ServicesCommercial Services National Outdoor Leadership School (NOLS) is a nonprofit organization that has been the leader in wilderness education since 1965. The non-profit company is based in Lander, WY and has subsidiaries in Canada. The company's mission is to help individuals become confident leaders through outdoor education. | Commercial Services |
| Lauchcyte | |
Entrega, Inc.
Entrega, Inc. Pharmaceuticals: MajorHealth Technology Entrega, Inc. develops oral drug delivery technologies. The firm’s platform enables novel applications in a variety of fields, such as disease management and tracking in the burgeoning mobile health arena. Its proprietary technology seeks to solve the oral delivery problem with an engineering solution that protects the payload and delivers biological molecules, drug substances and nanoparticles. The company was founded by Samir Mitragotri in 2010 and is headquartered in Boston, MA. | Health Technology |
Frequency Therapeutics, Inc.
 Frequency Therapeutics, Inc. BiotechnologyHealth Technology Frequency Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the business of developing therapeutics to activate a person's innate regenerative potential to restore function. The firm is also involved in creating and commercializing therapeutics to potentially transform the lives of individuals by repairing or reversing damage done to cells, tissue, and organs. The company was founded by Robert S. Langer, David L. Lucchino, Christopher R. Loosey, and Will J. McLean on November 13, 2014 and is headquartered in Lexington, MA. | Health Technology |
